Bevacizumab as first-line therapy for advanced breast cancer

R Bartsch; C de Vries; M Foedermayr; RM Mader; M Huber; Z Bago-Horvath; U Pluschnig; GG Steger; P Dubsky; F Fitzal; G Schreil; CC Zielinski; Simon Peter Gampenrieder; R Ziebermayr

Bevacizumab as first-line therapy for advanced breast cancer

R Bartsch, C de Vries, M Foedermayr, RM Mader, M Huber, Z Bago-Horvath, U Pluschnig, GG Steger, P Dubsky, F Fitzal, G Schreil, CC Zielinski, Simon Peter Gampenrieder, R Ziebermayr

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Abstract (Journal) › peer-review

Original language	English
Pages (from-to)	16-16
Journal	ONKOLOGIE
Volume	33
Publication status	Published - 2010

Cite this

Bartsch, R., de Vries, C., Foedermayr, M., Mader, RM., Huber, M., Bago-Horvath, Z., Pluschnig, U., Steger, GG., Dubsky, P., Fitzal, F., Schreil, G., Zielinski, CC., Gampenrieder, S. P., & Ziebermayr, R. (2010). Bevacizumab as first-line therapy for advanced breast cancer. ONKOLOGIE , 33, 16-16.

Bartsch, R ; de Vries, C ; Foedermayr, M et al. / Bevacizumab as first-line therapy for advanced breast cancer. In: ONKOLOGIE 2010 ; Vol. 33. pp. 16-16.

@article{f26d1f1b4cfa4058be7b98e66909d768,

title = "Bevacizumab as first-line therapy for advanced breast cancer",

author = "R Bartsch and {de Vries}, C and M Foedermayr and RM Mader and M Huber and Z Bago-Horvath and U Pluschnig and GG Steger and P Dubsky and F Fitzal and G Schreil and CC Zielinski and Gampenrieder, {Simon Peter} and R Ziebermayr",

year = "2010",

language = "English",

volume = "33",

pages = "16--16",

journal = "ONKOLOGIE ",

issn = "0378-584X",

}

Bartsch, R, de Vries, C, Foedermayr, M, Mader, RM, Huber, M, Bago-Horvath, Z, Pluschnig, U, Steger, GG, Dubsky, P, Fitzal, F, Schreil, G, Zielinski, CC, Gampenrieder, SP & Ziebermayr, R 2010, 'Bevacizumab as first-line therapy for advanced breast cancer', ONKOLOGIE , vol. 33, pp. 16-16.

Bevacizumab as first-line therapy for advanced breast cancer. / Bartsch, R; de Vries, C; Foedermayr, M et al.
In: ONKOLOGIE , Vol. 33, 2010, p. 16-16.

Research output: Contribution to journal › Abstract (Journal) › peer-review

TY - JOUR

T1 - Bevacizumab as first-line therapy for advanced breast cancer

AU - Bartsch, R

AU - de Vries, C

AU - Foedermayr, M

AU - Mader, RM

AU - Huber, M

AU - Bago-Horvath, Z

AU - Pluschnig, U

AU - Steger, GG

AU - Dubsky, P

AU - Fitzal, F

AU - Schreil, G

AU - Zielinski, CC

AU - Gampenrieder, Simon Peter

AU - Ziebermayr, R

PY - 2010

Y1 - 2010

M3 - Abstract (Journal)

SN - 0378-584X

VL - 33

SP - 16

EP - 16

JO - ONKOLOGIE

JF - ONKOLOGIE

ER -

Bartsch R, de Vries C, Foedermayr M, Mader RM, Huber M, Bago-Horvath Z et al. Bevacizumab as first-line therapy for advanced breast cancer. ONKOLOGIE . 2010;33:16-16.